As of Mar 24
| -0.04 / -1.75%|
The 1 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +166.67% increase from the last price of 2.25.
The current consensus among 1 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.